COMMUNIQUÉS West-GlobeNewswire

Altimmune Announces Notice of Allowance on Patent Covering Use of NasoShield in the U.S.
23/01/2018
Patent Will Specifically Cover Prophylactic and Post-Exposure Use of NasoShield in the U.S. Patents with Similar Protection Already Issued in Europe and Japan GAITHERSBURG, Md., Jan. 23, 2018 (GLOBE NEWSWIRE) -- [...]
BioCanCell Announces Terms of $25 Million Funding Round
23/01/2018
JERUSALEM, Jan. 23, 2018 (GLOBE NEWSWIRE) -- BioCanCell Ltd. (TASE: BICL ) (the “Company") , a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapies to [...]
Nephros to Present at NobleCon14
23/01/2018
SOUTH ORANGE, N.J., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Nephros, Inc. (OTCQB:NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid- [...]
KemPharm Receives Patent Grant for KP606, a Prodrug of Oxycodone
23/01/2018
Additional Patent Granted for the KP511-related family, a Prodrug of Hydromorphone CORALVILLE, Iowa, Jan. 23, 2018 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ: KMPH ), a clinical-stage specialty pharmaceutical company [...]
ProMIS Neurosciences Lead Product Candidate for Alzheimer’s Disease Shows Potential for Improved Therapeutic Potency versus Other Amyloid Beta-Directed Antibodies
23/01/2018
TORONTO and CAMBRIDGE, Mass., Jan. 23, 2018 (GLOBE NEWSWIRE) -- ProMIS Neurosciences, Inc. (TSX: PMN ) (OTCQB:ARFXF), a biotechnology company focused on the discovery and development of precision treatments for [...]
Voyager Therapeutics Announces FDA Clearance of Investigational New Drug Application for VY-AADC for Advanced Parkinson’s Disease
23/01/2018
CAMBRIDGE, Mass., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR ), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases today [...]
Millennium Blockchain Appoints Michael Terpin to Board of Advisors
23/01/2018
World-renowned blockchain pioneer and communications executive to chair advisory board LAS VEGAS, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Millennium Blockchain, Inc. (“THCT” or the “Company,”) (OTC:THCT) is pleased to [...]
Tonix Pharmaceuticals Receives Notice of Allowance for New U.S. Patent for the Active Ingredient in Tonmya® (Cyclobenzaprine HCl Sublingual Tablets)
23/01/2018
NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix) announced today that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. Patent [...]
Helius Medical Technologies Completes Reverse Split of its Class A Common Stock
23/01/2018
NEWTOWN, Pa., Jan. 23, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (TSX: HSM ) (TSX:HSM.WT) (OTCQB:HSDT) (“Helius” or the “Company”), a medical technology company focused on neurological wellness, [...]
Transactions in relation to share buyback program
23/01/2018
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Sharps Compliance Reports Fiscal 2018 Second Quarter Results
23/01/2018
Quarterly revenue of $11.1 million increased 15% over the prior year second quarter Retail market billings increased 57% Professional market billings improved 11% Government and Assisted Living market billings increased [...]
Genmab Announces 2017 Net Sales Figures for DARZALEX® (Daratumumab)
23/01/2018
Company Announcement Net sales of DARZALEX in 2017 totaled USD 1,242 million Genmab receives royalties on worldwide sales from Janssen Biotech, Inc. Copenhagen, Denmark; January 23, 2018 – Genmab A/S (Nasdaq Copenhagen [...]
ChromaDex Appoints Mark Friedman as General Counsel and Corporate Secretary
23/01/2018
IRVINE, Calif., Jan. 23, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated, science-based, nutraceutical company devoted to improving the way people age, announced today that it has appointed Mark [...]
ContraVir Pharmaceuticals to Present at NobleCon14
23/01/2018
EDISON, N.J., Jan. 23, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]
Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 90% Mark for Reported Primary Events
23/01/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Orion to investigate possible sale of Orion Diagnostica
23/01/2018
ORION CORPORATION STOCK EXCHANGE RELEASE 23 JANUARY 2018 at 12.20. p.m. EET Orion to investigate possible sale of Orion Diagnostica Orion Corporation has evaluated strategic alternatives of the Group's Orion Diagnostica [...]
NE Indiana Urology Partnering with UroChoice™ for Technology Needs
23/01/2018
INDIANAPOLIS, Jan. 23, 2018 (GLOBE NEWSWIRE) -- Northeast Indiana Urology, a team of 14 board-certified clinicians specializing in adult men’s and women’s urological care maintain more than 70 staff members over 11 [...]
Nexstim Plc receives R&D loan from Business Finland
23/01/2018
Company announcement, Helsinki, 23 January 2018, at 10:00 a.m. Nexstim Plc receives R&D loan from Business Finland Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), a medical technology company developing [...]
GENFIT: Official Launch of the NASH Pediatric Program, following PIP and PSP Agreement by EMA and FDA
23/01/2018
GENFIT: Official Launch of the NASH Pediatric Program, following PIP and PSP Agreement by EMA and FDA FDA (Food and Drug Administration) agrees with elafibranor's initial Pediatric Study Plan (PSP) for the launch of a [...]

Pages